Facephi Biometria, S.A. (ALPHI.PA)
EUR 1.6
(0.0%)
EUR 1.6
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 853.21 Thousand | -5.81 Million | -3.6 Million | 1.43 Million | -191.92 Thousand | 251.86 Thousand |
| Net Income | -4.3 Million | 1.02 Million | -853.38 Thousand | -1.82 Million | 1.71 Million | 852.55 Thousand |
| Depreciation & Amortization | 4.78 Million | 1.97 Million | 1.28 Million | 839.63 Thousand | 458.28 Thousand | 366.08 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4.98 Million | -6.79 Million | -3.98 Million | 980.75 Thousand | -2.85 Million | -246.96 Thousand |
| Other non-cash items | 5.36 Million | -2.02 Million | -50.09 Thousand | 1.44 Million | 482.8 Thousand | -719.81 Thousand |
| Investing Cash Flow | -9.83 Million | -2.2 Million | -2.13 Million | -2.66 Million | -985.85 Thousand | -983.71 Thousand |
| Investments in PPE | -1.51 Million | -2.06 Million | -2.55 Million | -2.29 Million | -816.53 Thousand | -503.36 Thousand |
| Acquisitions | - | 495.76 Thousand | -188.00 | -157.56 Thousand | -169.31 Thousand | - |
| Investment purchases | - | -171.99 Thousand | -63.76 Thousand | -206.43 Thousand | - | -480.35 Thousand |
| Sales/Maturities of investments | - | 9526.00 | 474.91 Thousand | 2.29 Million | - | - |
| Other Investing Activities | -8.31 Million | -468.33 Thousand | -1.00 | -2.3 Million | - | - |
| Financing Cash Flow | 9.54 Million | 8.6 Million | 1.3 Million | 6.63 Million | 1.12 Million | 906.26 Thousand |
| Debt repayment | -3.96 Million | -10.52 Thousand | -809.65 Thousand | -3.08 Million | -942.08 Thousand | -639.13 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -450.74 Thousand | -338.1 Thousand | -585.93 Thousand | -1.75 Million | -597.25 Thousand | -239.35 Thousand |
| Common Stock Issuance | - | 5.01 Million | 2.7 Million | 4.38 Million | 1.15 Million | 233.94 Thousand |
| Other Financing Activities | 6.03 Million | 5.53 Million | -1598.00 | 14.13 Million | 1.5 Million | 3.12 Million |
| Accounts receivables | -5.44 Million | -8.95 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 461.36 Thousand | 2.16 Million | - | - | - | - |
| Cash at beginning of period | 2.17 Million | 1.69 Million | 5.97 Million | 394.15 Thousand | 387.57 Thousand | 207.33 Thousand |
| Cash at end of period | 2.73 Million | 2.17 Million | 1.69 Million | 5.97 Million | 386.68 Thousand | 387.57 Thousand |
| Capital Expenditure | -1.51 Million | -2.06 Million | -2.55 Million | -2.29 Million | -816.53 Thousand | -503.36 Thousand |
| Effect of forex changes on cash | -3050.00 | -109.32 Thousand | 158.69 Thousand | 185.89 Thousand | 56.1 Thousand | 5815.00 |
| Net cash flow / Change in cash | 561.21 Thousand | 474.84 Thousand | -4.28 Million | 5.58 Million | -894.00 | 180.24 Thousand |
| Free Cash Flow | -664.63 Thousand | -7.88 Million | -6.15 Million | -860.99 Thousand | -1 Million | -251.49 Thousand |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 192.75 Thousand | 192.75 Thousand | -2.34 Million | -2.34 Million | 1.08 Million | 1.02 Million |
| Depreciation & Amortization | - | - | - | - | - | 1.97 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | -6.79 Million |
| Other non-cash items | -192.75 Thousand | -192.75 Thousand | 2.34 Million | 2.34 Million | -1.08 Million | -2.02 Million |
| Investing Cash Flow | - | - | - | - | - | -2.2 Million |
| Investments in PPE | - | - | - | - | - | -2.06 Million |
| Acquisitions | - | - | - | - | - | 495.76 Thousand |
| Investment purchases | - | - | - | - | - | -171.99 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 9526.00 |
| Other Investing Activities | - | - | - | - | - | -468.33 Thousand |
| Financing Cash Flow | - | - | - | - | - | 8.6 Million |
| Debt repayment | - | - | - | - | - | -10.52 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -338.1 Thousand |
| Common Stock Issuance | - | - | - | - | - | 5.01 Million |
| Other Financing Activities | - | - | - | - | - | 5.53 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | - | - | 1.69 Million |
| Cash at end of period | - | - | - | - | - | 2.17 Million |
| Capital Expenditure | - | - | - | - | - | -2.06 Million |
| Effect of forex changes on cash | - | - | - | - | - | -109.32 Thousand |
| Net cash flow / Change in cash | - | - | - | - | - | 474.84 Thousand |
| Free Cash Flow | - | - | - | - | - | -7.88 Million |
9503
HXG
8894
CZR
CTO
3402